TY - JOUR
T1 - Disease Modeling in Stem Cell-Derived 3D Organoid Systems
AU - Dutta, Devanjali
AU - Heo, Inha
AU - Clevers, Hans
N1 - Funding Information:
We are grateful to Joep Beumer and Jasper Mullenders for discussions and critical reading of the manuscript. Shigella flexneri strains shown in Figure 3 were a kind gift from Prof. Philippe Sansonetti (Pasteur Institute, France). D.D. is the recipient of a VENI grant from the Netherlands Organisation for Scientific Research (NWO-ALW, 016.Veni.171.015). I.H. is the recipient of a VENI grant from the Netherlands Organisation for Scientific Research (NWO-ALW, 863.14.002) and was supported by Marie Curie fellowships from the European Commission (Proposal 330571 FP7-PEOPLE-2012-IIF). H.C. is named as the inventor of several patents related to Lgr5 stem cell-based organoid technology.
Publisher Copyright:
© 2017 Elsevier Ltd
PY - 2017
Y1 - 2017
N2 - Organoids are 3D in vitro culture systems derived from self-organizing stem cells. They can recapitulate the in vivo architecture, functionality, and genetic signature of original tissues. Thus, organoid technology has been rapidly applied to understanding stem cell biology, organogenesis, and various human pathologies. The recent development of human patient-derived organoids has enabled disease modeling with precision, highlighting their great potential in biomedical applications, translational medicine, and personalized therapy. In light of recent breakthroughs using organoids, it is only apt that we appreciate the advantages and shortcomings of this technology to exploit its full potential. We discuss recent advances in the application of organoids in studying cancer and hereditary diseases, as well as in the examination of host cell-microorganism interactions.
AB - Organoids are 3D in vitro culture systems derived from self-organizing stem cells. They can recapitulate the in vivo architecture, functionality, and genetic signature of original tissues. Thus, organoid technology has been rapidly applied to understanding stem cell biology, organogenesis, and various human pathologies. The recent development of human patient-derived organoids has enabled disease modeling with precision, highlighting their great potential in biomedical applications, translational medicine, and personalized therapy. In light of recent breakthroughs using organoids, it is only apt that we appreciate the advantages and shortcomings of this technology to exploit its full potential. We discuss recent advances in the application of organoids in studying cancer and hereditary diseases, as well as in the examination of host cell-microorganism interactions.
KW - Animals
KW - Disease Models, Animal
KW - Humans
KW - Neoplasms
KW - Organoids
KW - Pluripotent Stem Cells
KW - Journal Article
KW - Review
UR - http://www.scopus.com/inward/record.url?scp=85015718933&partnerID=8YFLogxK
U2 - 10.1016/j.molmed.2017.02.007
DO - 10.1016/j.molmed.2017.02.007
M3 - Review article
C2 - 28341301
AN - SCOPUS:85015718933
SN - 1471-4914
VL - 23
SP - 393
EP - 410
JO - Trends in molecular medicine
JF - Trends in molecular medicine
IS - 5
ER -